Lyell Immunopharma Presents New Clinical Data from Ongoing Trial of Ronde-Cel Showing High Rates of Durable Complete Responses in Patients with Large B-cell Lymphoma at the 67th ASH Annual Meeting and Exposition
93% overall response and 76% complete response rates with median progression-free survival…
BioNTech and OncoC4 Announce Clinically Meaningful Overall Survival Benefit for Selective Treg Modulator Gotistobart in Patients with Previously Treated Squamous Non-Small Cell Lung Cancer
Selective Treg modulator gotistobart (BNT316/ONC-392) showed a reduction in the risk of…
Abu Dhabi signs agreements and explores opportunities to strengthen partnerships with India and Singapore
ABU DHABI, Dec. 6, 2025 /PRNewswire/ -- The Abu Dhabi economic delegation,…
Cerevance Showcases Positive Phase 2 Results Demonstrating Significant Reduction in OFF Time with Solengepras as an Adjunctive Treatment in Parkinsons Disease
December 05, 2025 21:00 ET | Source: Cerevance, Inc. Phase 2 results…
ORIC Pharmaceuticals Presents Potential Best-in-Class Profile for Enozertinib with Robust Systemic and CNS Activity in 1L and 2L NSCLC Patients with EGFR Exon 20 Mutations at the ESMO Asia Congress 2025
December 05, 2025 20:00 ET | Source: ORIC Pharmaceuticals Highly differentiated 1L…
Chery Partners with 2025 Asian Youth Para Games, Taking Center Stage in Global Sports with Passion and Aspiration
DUBAI, UAE, Dec. 5, 2025 /PRNewswire/ -- On December 4, Chery held a…
Eureka Ergonomic Launches Luxury Leather Office Chair Collection with Holiday Discounts Up to 40%
Los Angeles, CA, Dec. 04, 2025 (GLOBE NEWSWIRE) -- As professionals increasingly…
Kia Marks 80Year Journey with Ceremony and Exhibition Celebrating its Heritage and Vision
Anniversary ceremony held at Kia Vision Square to commemorate significant milestone, attended…
Hyundai Motor Group Fosters Collaboration with Hydrogen Industry Leaders at Hydrogen Council Global CEO Summit
Hyundai Motor Group co-hosted the Hydrogen Council Global CEO Summit from December…
ORIC Pharmaceuticals Presents Enozertinib Data in NSCLC Patients with HER2 Exon 20 Mutations at the ESMO Asia Congress 2025
December 05, 2025 01:00 ET | Source: ORIC Pharmaceuticals Systemic activity of…
